title: Splicing therapeutics in SMN2 and APOB.
abstract: Splicing therapeutics are defined as the deliberate modification of RNA splicing to achieve therapeutic goals. Various techniques for splicing therapeutics have been described, and most of these involve the use of antisense oligonucleotide-based compounds that target key elements in the pre-mRNA to control splicing in the nucleus. In this review, recent developments in splicing therapeutics for the treatment of two specific diseases are described: correcting the alternative splicing of survival of motor neuron (SMN)2 pre-mRNA to compensate for the defective SMN1 gene in spinal muscular atrophy, and re-engineering the splicing of apolipoprotein B pre-mRNA to lower circulating cholesterol levels.
authors.affiliation: University College London Medical School, Department of Endocrinology, Hampstead Campus, London, UK. b.khoo@ucl.ac.uk
authors.forename: Bernard
authors.initials: B
authors.lastname: Khoo
authors.forename: Adrian R
authors.initials: AR
authors.lastname: Krainer